tradingkey.logo

Integer Holdings Corp

ITGR
64.570USD
+1.250+1.97%
Close 10/31, 16:00ETQuotes delayed by 15 min
2.26BMarket Cap
26.03P/E TTM

Integer Holdings Corp

64.570
+1.250+1.97%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Integer Holdings Corp

Currency: USD Updated: 2025-10-31

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Integer Holdings Corp's Score

Industry at a Glance

Industry Ranking
51 / 210
Overall Ranking
145 / 4618
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 11 analysts
Hold
Current Rating
86.000
Target Price
+35.82%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Integer Holdings Corp Highlights

StrengthsRisks
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. It operates through Medical segment, which includes the cardio and vascular; cardiac rhythm management and neuromodulation, and advanced surgical; orthopedics and portable medical product lines. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 28.94% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.72B.
Undervalued
The company’s latest PE is 25.48, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 40.70M shares, decreasing 5.10% quarter-over-quarter.
Held by Andreas Halvorsen
Star Investor Andreas Halvorsen holds 1.28M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.25.

Financial Health

Currency: USD Updated: 2025-10-31

The company's current financial score is 6.96, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 467.69M, representing a year-over-year increase of 8.41%, while its net profit experienced a year-over-year increase of 11.96%.

Score

Industry at a Glance

Previous score
6.96
Change
0

Financials

4.79

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

6.24

Operational Efficiency

7.28

Growth Potential

9.06

Shareholder Returns

7.46

Integer Holdings Corp's Company Valuation

Currency: USD Updated: 2025-10-31

The company’s current valuation score is 5.47, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 25.48, which is 117.28% below the recent high of 55.36 and 1.94% above the recent low of 24.99.

Score

Industry at a Glance

Previous score
5.47
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 51/210
No Data

Earnings Forecast

Currency: USD Updated: 2025-10-31

The company’s current earnings forecast score is 8.18, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Integer Holdings Corp is 87.00, with a high of 95.00 and a low of 77.00.

Score

Industry at a Glance

Previous score
8.18
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 11 analysts
Hold
Current Rating
86.000
Target Price
+35.82%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

89
Total
4
Median
7
Average
Company name
Ratings
Analysts
Integer Holdings Corp
ITGR
11
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-31

The company’s current price momentum score is 6.73, which is higher than the Healthcare Equipment & Supplies industry's average of 6.65. Sideways: Currently, the stock price is trading between the resistance level at 97.04 and the support level at 47.05, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.68
Change
0.05

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(1)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-8.023
Sell
RSI(14)
18.250
Oversold
STOCH(KDJ)(9,3,3)
4.800
Oversold
ATR(14)
5.878
High Vlolatility
CCI(14)
-84.264
Neutral
Williams %R
94.859
Oversold
TRIX(12,20)
-1.285
Sell
StochRSI(14)
93.588
Buy
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
66.278
Sell
MA10
80.261
Sell
MA20
91.967
Sell
MA50
99.570
Sell
MA100
106.717
Sell
MA200
115.789
Sell

Institutional Confidence

Currency: USD Updated: 2025-10-31

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 116.18%, representing a quarter-over-quarter decrease of 1.11%. The largest institutional shareholder is The Vanguard, holding a total of 3.90M shares, representing 11.14% of shares outstanding, with 2.41% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
4.82M
-0.02%
The Vanguard Group, Inc.
Star Investors
3.90M
+3.57%
Invesco Advisers, Inc.
1.36M
+4.42%
Dimensional Fund Advisors, L.P.
1.34M
-12.60%
State Street Investment Management (US)
1.33M
+1.03%
Viking Global Investors LP
Star Investors
1.28M
+9.06%
EARNEST Partners, LLC
1.15M
+0.30%
AllianceBernstein L.P.
1.11M
+885.11%
Geode Capital Management, L.L.C.
819.09K
+3.94%
Columbia Threadneedle Investments (UK)
809.40K
-3.30%
1
2

Risk Assessment

Currency: USD Updated: 2025-10-31

The company’s current risk assessment score is 8.19, which is higher than the Healthcare Equipment & Supplies industry's average of 4.56. The company's beta value is 0.92. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
8.19
Change
0
Beta vs S&P 500 index
0.92
VaR
+3.01%
240-Day Maximum Drawdown
+56.14%
240-Day Volatility
+43.41%

Return

Best Daily Return
60 days
+3.51%
120 days
+3.51%
5 years
+15.59%
Worst Daily Return
60 days
-32.28%
120 days
-32.28%
5 years
-32.28%
Sharpe Ratio
60 days
-2.44
120 days
-2.06
5 years
+0.07

Risk Assessment

Maximum Drawdown
240 days
+56.14%
3 years
+56.14%
5 years
+56.14%
Return-to-Drawdown Ratio
240 days
-0.93
3 years
+0.02
5 years
-0.07
Skewness
240 days
-6.89
3 years
-3.81
5 years
-2.66

Volatility

Realised Volatility
240 days
+43.41%
5 years
+35.22%
Standardised True Range
240 days
+5.16%
5 years
+4.12%
Downside Risk-Adjusted Return
120 days
-167.80%
240 days
-167.80%
Maximum Daily Upside Volatility
60 days
+45.00%
Maximum Daily Downside Volatility
60 days
+80.37%

Liquidity

Average Turnover Rate
60 days
+1.16%
120 days
+1.53%
5 years
--
Turnover Deviation
20 days
-24.92%
60 days
+12.07%
120 days
+47.75%

Peer Comparison

Healthcare Equipment & Supplies
Integer Holdings Corp
Integer Holdings Corp
ITGR
7.36 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Boston Scientific Corp
Boston Scientific Corp
BSX
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hologic Inc
Hologic Inc
HOLX
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI